Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Other Non-Current Liabilities (2020 - 2026)

Bluejay Diagnostics' Other Non-Current Liabilities history spans 2 years, with the latest figure at $12321.0 for Q4 2023.

  • On a quarterly basis, Other Non-Current Liabilities fell 22.13% to $12321.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $12321.0, a 22.13% decrease, with the full-year FY2023 number at $12321.0, down 22.13% from a year prior.
  • Other Non-Current Liabilities hit $12321.0 in Q4 2023 for Bluejay Diagnostics, down from $13220.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for BJDX hit a ceiling of $15823.0 in Q4 2022 and a floor of $12321.0 in Q4 2023.